ESCRS - Evaluating the Emerging Clinical Benefit of OCT Angiography in Practice ;
ESCRS - Evaluating the Emerging Clinical Benefit of OCT Angiography in Practice ;

Evaluating the Emerging Clinical Benefit of OCT Angiography in Practice

Evaluating the Emerging Clinical Benefit of OCT Angiography in Practice
This supplement, sponsored by Zeiss, was published at the 17th EURETINA Congress in Barcelona, Spain, in association with ET Today, the daily congress newspaper produced by EuroTimes. In the supplement,  key opinion leaders discuss how  Ocular Coherence Tomography Angiography  (OCTA) can help surgeons improve their diagnosis and treatment of retinal disease. OCTA Promising For Identifying Vascular Changes Earlier in Diabetic Patients Prof Sebastian Wolf Emergency Clinical Value Of OCTA Prof  Pravin A. Dugel Adding OCTA To Your Practice Prof  Frank G. Holz Download Supplement - click here
Latest Articles
Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Read more...

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

Read more...

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

Read more...

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Read more...

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Read more...

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

Read more...

ESCRS Heritage Programme

Visionaries past and present.

Read more...

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

Read more...

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Read more...

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

Read more...

;